Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Month: April 2016

7 / 9

Indian Automobile Sales for the month of March 2016

Today we bring you a mini version of our Monthly SparkPlug Report – a summary of the sales made during the month of March. We initiated this SparkPlug ...

Capital Mind Wishes You All A Happy Ugadi – Get ₹1500 OFF on Annual Membership

It’s festive season folks!! We wish you all a very Happy and Prosperous Ugadi. Let the days ahead bring you joys, health and wealth in abundance. And to ...

Portfolios: Adding [Stock]

 ...

Macquarie Bank exits Banswara Syntex with stake sale to Kotak Mahindra

Banswara Syntex Banswara Syntex is a vertically integrated textile mill manufacturing man-made synthetic blended Yarn, wool and wool mixed yarn, all type of ...

Amansa Capital continues to dump Kirloskar Brothers now at 1.68%

Kirloskar Brothers Kirloskar Brothers Limited (KBL) is a world class pump manufacturing company with expertise in engineering and manufacture of systems for ...

On Slack: Maruti’s Operating Margins Under Pressure, Are Infosys’ Founders Not Happy With Vishal Sikka?, Taxing Times For Kingfisher Airlines Staff Continue and much more…

The Slack Discussions The Slack group at Capital Mind Premium has been extremely active and if you haven’t been there, pop us a note by replying to this ...

Exclusive: Lupin Pharmaceuticals slapped form 483 for Mandideep facility

Welcome to the third and final part of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s ...
04-Lupin-fda-3-facilities-Mandideep.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for Goa facility

Welcome to the second of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s facilities. If ...
03-Lupin-fda-3-facilities-Goa.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for Aurangabad facility

Welcome to the first of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s facilities. If ...
02-Lupin-fda-3-facilities-Aurangabad.png

Exclusive: Lupin Pharmaceuticals slapped form 483 for 3 facilities

Today we at Capital Mind bring you some exclusive articles. This follows our earlier post on Lupin’s Mandideep facility FDA inspection which was brought to ...
01-Lupin-fda-3-facilities.png